We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£490.00
It has never been this cheap. We have no record of a lower price.
£490 today · cheaper than every other day in the last 3 months
Renin-Angiotensin System-Blocking Drug Outlook 2023-2028
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 25 days · 25 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 25 days • 1 price levels
Price Analysis
Most common price: £490 (25 days, 100.0%)
Price range: £490 - £490
Price levels: 1 different prices over 25 days
Description
Key Features
Provides latent demand estimates for renin-angiotensin system-blocking cardiovascular drugs across 10,833 U.S. zip codes.
Includes potential industry earnings (P.I.E.) data to help identify market opportunities through 2028.
Offers comparative benchmarks showing the percent share of each zip code relative to its state and the United States.
Delivers detailed statistical analysis designed to assist with distribution and market planning strategies.
Covers a comprehensive outlook period spanning from 2023 to 2028 for the cardiovascular drug industry.
Product Specifications
- Format
- paperback
- ASIN
- B0BSWGGHST
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 09 January 2023
- Listed Since
- 27 January 2023
Similar Products You Might Like
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in China
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in Japan
Renin-Angiotensin System-Blocking Drug Outlook 2023-2028
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India
US Anti-Hypertensive Diuretic Drug Outlook 2023-2028
The 2013-2018 Outlook for Anti-Hypertensive Drugs in India
The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics
The 2021-2026 World Outlook for Antihypertensive Drugs
The 2021-2026 World Outlook for Ace Inhibitor Vasodilator Pharmaceuticals
Blood Pressure Monitoring Outlook 2023-2028 US Zip Codes
The 2016-2021 Outlook for Ace Inhibitor Vasodilator Pharmaceuticals in Japan
The 2016-2021 World Outlook for Anti-Hypertensive Drugs
The 2013-2018 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in India
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in Japan
The 2013-2018 Outlook for Thiazides and Related Diuretic Agents in India
The 2021-2026 World Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in China
Heart Failure Drugs US Zip Code Outlook 2023-2028 Study
The 2013-2018 Outlook for Coronary Vasodilator Pharmaceuticals in India
Anticoagulant Reversal Drugs Outlook 2023-2028 US Zip Codes
The 2016-2021 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in Japan
The 2016-2021 Outlook for Calcium Channel Blocker Vasodilator Pharmaceuticals in Greater China
The 2023-2028 Outlook for Percutaneous Coronary Interventions for US Zip Codes